Problems in the control of systolic blood pressure Luis M. Ruilope Editor’s Commentary Pages: 173 - 174
Serum uric acid as a cardiovascular risk factor for heart disease Michael H. Alderman OriginalPaper Pages: 184 - 189
Serum uric acid is not an independent risk factor for coronary heart disease S. Goya Wannamethee OriginalPaper Pages: 190 - 196
Resistant hypertension and the birmingham hypertension square Dirk C. FelmedenGregory Y. H. Lip OriginalPaper Pages: 203 - 208
Are sleep-related breathing disorders important contributing factors to the production of essential hypertension? Donald S. SilverbergArie Oksenberg OriginalPaper Pages: 209 - 215
Comparison of antihypertensive treatment in preventing cardiovascular events in elderly diabetic patients Franz H. Messerli Clinical Trials Report Pages: 225 - 225
Effects of ACE Inhibitors, Calcium Antagonists, and Other Blood Pressure lowering Drugs Roopal B. ThakkarSuzanne Oparil Clinical trials report Pages: 227 - 228
Primary aldosteronism: Rare bird or common cause of secondary hypertension? Michael Stowasser OriginalPaper Pages: 230 - 239
Aldosterone antagonists in the treatment of hypertension and target organ damage Sanjay RajagopalanBertram Pitt OriginalPaper Pages: 240 - 248
Mental stress as a causal factor in the development of hypertension and cardiovascular disease Thomas G. Pickering OriginalPaper Pages: 249 - 254
The role of the nervous system in hypertension J. Michael WyssScott H. Carlson OriginalPaper Pages: 255 - 262
Role of central mineralocorticoid receptors in cardiovascular disease Celso E. Gomez-SanchezElise P. Gomez-Sanchez OriginalPaper Pages: 263 - 269